185 related articles for article (PubMed ID: 25670670)
1. Validation of tissue microarray for molecular profiling of canine and feline mammary tumours.
Muscatello LV; Sarli G; Beha G; Asproni P; Millanta F; Poli A; De Tolla LJ; Benazzi C; Brunetti B
J Comp Pathol; 2015; 152(2-3):153-60. PubMed ID: 25670670
[TBL] [Abstract][Full Text] [Related]
2. Validation of usefulness of tissue microarray technology in primary tumours of the canine and feline central nervous system.
Wohlsein P; Recker T; Rohn K; Baumgärtner W
J Comp Pathol; 2012 May; 146(4):320-6. PubMed ID: 22000078
[TBL] [Abstract][Full Text] [Related]
3. Validation of a low-cost modified technique for constructing tissue microarrays for canine mammary tumor analysis.
Silva FB; Leite Jda S; de Mello MF; Ferreira AM
Pathol Res Pract; 2016 Sep; 212(9):783-90. PubMed ID: 27461825
[TBL] [Abstract][Full Text] [Related]
4. Design, construction, and analysis of cell line arrays and tissue microarrays for gene expression analysis.
Gately K; Kerr K; O'Byrne K
Methods Mol Biol; 2011; 784():139-53. PubMed ID: 21898218
[TBL] [Abstract][Full Text] [Related]
5. Molecular phenotype of primary mammary tumours and distant metastases in female dogs and cats.
Beha G; Muscatello LV; Brunetti B; Asproni P; Millanta F; Poli A; Benazzi C; Sarli G
J Comp Pathol; 2014; 150(2-3):194-7. PubMed ID: 24060151
[TBL] [Abstract][Full Text] [Related]
6. Comparison of steroid receptor expression in normal, dysplastic, and neoplastic canine and feline mammary tissues.
Millanta F; Calandrella M; Bari G; Niccolini M; Vannozzi I; Poli A
Res Vet Sci; 2005 Dec; 79(3):225-32. PubMed ID: 16054892
[TBL] [Abstract][Full Text] [Related]
7. Identification of triple-negative and basal-like canine mammary carcinomas using four basal markers.
Kim NH; Lim HY; Im KS; Kim JH; Sur JH
J Comp Pathol; 2013 May; 148(4):298-306. PubMed ID: 23079102
[TBL] [Abstract][Full Text] [Related]
8. Progesterone receptors in normal, dysplastic and tumourous feline mammary glands. Comparison with oestrogen receptors status.
Martín de las Mulas J; Van Niel M; Millán Y; Ordás J; Blankenstein MA; Van Mil F; Misdorp W
Res Vet Sci; 2002 Apr; 72(2):153-61. PubMed ID: 12027597
[TBL] [Abstract][Full Text] [Related]
9. Prognostic studies of canine and feline mammary tumours: the need for standardized procedures.
Matos AJ; Baptista CS; Gärtner MF; Rutteman GR
Vet J; 2012 Jul; 193(1):24-31. PubMed ID: 22296767
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of clinicopathological characteristics and oestrogen receptor gene expression in oestrogen receptor-negative, progesterone receptor-positive canine mammary carcinomas.
Kim NH; Lim HY; Im KS; Shin JI; Kim HW; Sur JH
J Comp Pathol; 2014 Jul; 151(1):42-50. PubMed ID: 24913515
[TBL] [Abstract][Full Text] [Related]
11. Metallothionein expression in canine and feline mammary and melanotic tumours.
Dincer Z; Jasani B; Haywood S; Mullins JE; Fuentealba IC
J Comp Pathol; 2001; 125(2-3):130-6. PubMed ID: 11578128
[TBL] [Abstract][Full Text] [Related]
12. Molecular phenotype in mammary tumours of queens: correlation between primary tumour and lymph node metastasis.
Brunetti B; Asproni P; Beha G; Muscatello LV; Millanta F; Poli A; Benazzi C; Sarli G
J Comp Pathol; 2013 Feb; 148(2-3):206-13. PubMed ID: 22819018
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cats.
Murakami Y; Tateyama S; Rungsipipat A; Uchida K; Yamaguchi R
J Vet Med Sci; 2000 Jul; 62(7):743-50. PubMed ID: 10945293
[TBL] [Abstract][Full Text] [Related]
14. The dog as a natural animal model for study of the mammary myoepithelial basal cell lineage and its role in mammary carcinogenesis.
Rasotto R; Goldschmidt MH; Castagnaro M; Carnier P; Caliari D; Zappulli V
J Comp Pathol; 2014; 151(2-3):166-80. PubMed ID: 24975897
[TBL] [Abstract][Full Text] [Related]
15. Analysis of Hypoxia-Inducible Factor-1α Expression Relative to Other Key Factors in Malignant Canine Mammary Tumours.
Shin JI; Lim HY; Kim HW; Seung BJ; Sur JH
J Comp Pathol; 2015; 153(2-3):101-10. PubMed ID: 26145724
[TBL] [Abstract][Full Text] [Related]
16. Four cases of cell cannibalism in highly malignant feline and canine tumors.
Ferreira FC; Soares MJ; Carvalho S; Borralho L; Vicente G; Branco S; Correia J; Peleteiro MC
Diagn Pathol; 2015 Nov; 10():199. PubMed ID: 26525147
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic significance of CK19 in canine malignant mammary tumours.
Gama A; Alves A; Schmitt F
Vet J; 2010 Apr; 184(1):45-51. PubMed ID: 19264518
[TBL] [Abstract][Full Text] [Related]
18. Activation of AKT in feline mammary carcinoma: a new prognostic factor for feline mammary tumours.
Maniscalco L; Iussich S; de Las Mulas JM; Millán Y; Biolatti B; Sasaki N; Nakagawa T; De Maria R
Vet J; 2012 Jan; 191(1):65-71. PubMed ID: 21282070
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine carcinoma of the mammary gland in a dog.
Nakahira R; Michishita M; Yoshimura H; Hatakeyama H; Takahashi K
J Comp Pathol; 2015; 152(2-3):188-91. PubMed ID: 25670668
[TBL] [Abstract][Full Text] [Related]
20. Molecular portrait-based correlation between primary canine mammary tumor and its lymph node metastasis: possible prognostic-predictive models and/or stronghold for specific treatments?
Beha G; Brunetti B; Asproni P; Muscatello LV; Millanta F; Poli A; Sarli G; Benazzi C
BMC Vet Res; 2012 Nov; 8():219. PubMed ID: 23146872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
